| Human |
| |
B cell |
B cell (ALL) |
314 |
9 |
CD19+ B cells from patients with acute lymphoblastic leukaemia (ALL) |
| |
|
B cell (CLL) |
767 |
16 |
CD19+ B cells from patients with chronic lymphoid leukaemia (CLL) |
| |
|
B cell |
464 |
45 |
The rest of the CD19+ B cells |
| |
T cell |
CD4+ T cell |
619 |
55 |
|
| |
|
CD8+ T cell |
189 |
29 |
|
| |
|
T cell |
231 |
30 |
Mixture of CD4+ and CD8+ T cells |
| |
|
T cell (ALL) |
230 |
3 |
T cells from patients with ALL |
| |
|
Treg |
72 |
10 |
Regulatory T cells (Tregs) |
| |
|
Jurkat |
131 |
22 |
Acute T cell leukaemia cell line |
| |
NK |
NK |
149 |
15 |
Natural killer cells (NKs) |
| |
PBL |
PBL |
175 |
3 |
Peripheral blood lymphocytes (PBLs) |
| |
Monocyte |
Monocyte |
462 |
48 |
|
| |
|
THP-1 |
164 |
26 |
Acute monocytic leukaemia cell line |
| |
DC |
DC (monocyte-derived dendritic cell, MDDC) |
334 |
25 |
Monocyte-derived dendritic cells (MDDCs) |
| |
|
DC (tissue resident) |
77 |
9 |
Dendritic cells (DCs) from cord blood, peripheral blood and skin, among others. Plasmacytoid DCs are also included in this group. |
| |
Macrophage |
Monocyte-derived macrophage (MDM) |
253 |
23 |
|
| |
|
Macrophage (lung) |
132 |
7 |
Alveolar macrophages |
| |
Haematopoietic stem cell |
Haematopoietic stem cell (blood) |
198 |
24 |
CD34+ cells from cord blood or peripheral blood |
| |
|
Haematopoietic stem cell (MDS,bone marrow) |
195 |
3 |
CD34+ cells from the bone marrow of patients with myelodysplastic syndromes (MDS) |
| |
|
Haematopoietic stem cell (bone marrow) |
97 |
12 |
CD34+ cells from the bone marrow of individuals without MDS |
| |
Mononuclear cell |
Bone marrow mononuclear cell (BMMC) |
791 |
11 |
Bone marrow mononuclear cells (BMMCs) from patients with acute myeloid leukaemia (AML) |
| |
|
PBMC (breast cancer) |
87 |
2 |
Peripheral blood mononuclear cells (PBMCs) from patients with breast cancer |
| |
|
PBMC (CLL) |
77 |
2 |
PBMCs from patients with CLL |
| |
|
PBMC (COPD) |
94 |
1 |
PBMCs from patients with chronic obstructive pulmonary disease (COPD) |
| |
|
PBMC (JIA) |
278 |
11 |
PBMCs from patients with juvenile idiopathic arthritis (JIA) |
| |
|
PBMC (transplant) |
150 |
3 |
PBMCs from recipients after kidney or liver transplant |
| |
|
PBMC (MS) |
250 |
2 |
PBMCs from patients with multiple sclerosis (MS) |
| |
|
PBMC (miscellaneous) |
650 |
40 |
PBMCs from miscellaneous and other experimental conditions |
| |
|
PBMC (normal) |
564 |
39 |
PBMCs from healthy individuals |
| |
Plasma cell |
Plasma cell |
1771 |
18 |
Mainly from patients with multiple myeloma |
| |
Neutrophil |
PMN/neutrophil |
457 |
21 |
Polymorphonuclear leukocytes (PMNs), neutrophils |
| |
|
|
|
|
|
| Mouse |
| |
B cell |
B cell |
404 |
60 |
CD19+ B cells |
| |
|
B cell precursor |
149 |
20 |
Including pre-B, pro-B and other B cell precursors |
| |
T cell |
CD4+ T cell |
652 |
107 |
|
| |
|
CD8+ T cell |
318 |
41 |
|
| |
|
T cell |
110 |
22 |
Mixture of CD4+ and CD8+ T cells |
| |
|
Treg |
176 |
42 |
|
| |
|
Thymocyte |
267 |
24 |
Thymocytes are white blood cells situated in the thymus. They are generally T cells with distinct maturational stages based on the expression of the CD4 and CD8 cell surface markers. |
| |
NK |
NK |
85 |
20 |
|
| |
DC |
DC (bone marrow) |
147 |
20 |
DCs from bone marrow |
| |
|
DC (spleen) |
135 |
23 |
DCs from the spleen |
| |
|
DC (other) |
130 |
12 |
Primary DCs from other tissue |
| |
Haematopoietic stem cell |
Haematopoietic stem cell (LSK) |
249 |
43 |
CD34+ haematopoietic stem cells |
| |
|
Haematopoietic stem cell (LSK) |
208 |
46 |
Lineage negative Sca-1 positive Kit positive HSCs |
| |
Macrophage |
Macrophage (bone marrow) |
571 |
38 |
Macrophages derived from bone marrow |
| |
|
Macrophage (peritoneal) |
95 |
15 |
Macrophages from the peritoneal |
| |
|
Macrophage (other) |
111 |
20 |
Macrophages from other tissue |
| |
Splenocyte |
Splenocyte |
122 |
8 |
Splenocytes are a mixture of different white blood cell types situated in the immune organ spleen. |
